{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T21:08:46Z","timestamp":1777583326024,"version":"3.51.4"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Several studies have reported the epidemiology of immune thrombocytopenia (ITP) among children in the United States and other countries. However, recent trends in ITP among hospitalized children and hospital course remain unknown at a national level in the United States.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method:<\/jats:title><jats:p>Hospital discharge records of patients with ITP aged 19 years and younger were obtained for the years 2003, 2006, 2009, and 2012 using the Kids\u2019 Inpatient Database. Data were weighted to estimate the annual hospitalization rates in the United States with trend analyses. Multivariable regression models were used to ascertain trends of health care utilizations, hospitalization costs, and length of stay.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Total annual hospitalization rates due to ITP ranged from 6.13 per 100,000 children in 2003 to 6.22 per 100,000 children in 2012 (<jats:italic toggle=\"yes\">P<\/jats:italic><jats:sub>trend<\/jats:sub>=0.86). The lowest proportions of hospitalizations were observed in August. The proportions of inpatients treated with intravenous immunoglobulin increased from 18.5% in 2003 to 39.9% (<jats:italic toggle=\"yes\">P<\/jats:italic><jats:sub>trend<\/jats:sub>&lt; 0.001), while those examined with bone marrow aspiration decreased from 7.8% in 2003 to 6.5% in 2012 (<jats:italic toggle=\"yes\">P<\/jats:italic><jats:sub>trend<\/jats:sub>=0.01). Total hospitalization costs and length of stay changed from $6147 and 3.78 days in 2003 to $9328 and 2.55 days in 2012.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>We provided insights of epidemiology of ITP and health care utilizations in the United States. Further studies, including cost-effective analyses, will be required to justify the increasing trends in health care costs and intravenous immunoglobulin.<\/jats:p><\/jats:sec>","DOI":"10.1097\/mph.0000000000001083","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T19:50:02Z","timestamp":1515786602000},"page":"e140-e144","source":"Crossref","is-referenced-by-count":10,"title":["Nationwide Trend Analysis of Pediatric Inpatients With Immune Thrombocytopenia in the United States"],"prefix":"10.1097","volume":"40","author":[{"given":"Yusuke","family":"Okubo","sequence":"first","affiliation":[{"name":"Harvard TH Chan School of Public Health"},{"name":"Department of Social Medicine, National Research Institute for Child Health and Development, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhiko","family":"Handa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Massachusetts General Hospital for Children and Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group","volume":"113","author":"Rodeghiero","year":"2009","journal-title":"Blood"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1182\/blood-2009-06-225565","article-title":"International consensus report on the investigation and management of primary immune thrombocytopenia","volume":"115","author":"Provan","year":"2010","journal-title":"Blood"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MPH.0b013e318271f457","article-title":"ITP in children: pathophysiology and current treatment approaches","volume":"35","author":"D\u2019Orazio","year":"2013","journal-title":"J Pediatr Hematol Oncol"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ajh.21616","article-title":"The incidence of immune thrombocytopenic purpura in children and adults: a critical review of published reports","volume":"85","author":"Terrell","year":"2010","journal-title":"Am J Hematol"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/08035250410025294","article-title":"Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease","volume":"94","author":"Zeller","year":"2005","journal-title":"Acta Paediatr"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1067\/S0022-3476(03)00535-3","article-title":"A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group","volume":"143","author":"Kuhne","year":"2003","journal-title":"J Pediatr"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(01)07219-1","article-title":"Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study","volume":"358","author":"Kuhne","year":"2001","journal-title":"Lancet"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/pr.2015.6","article-title":"Association of primary immune thrombocytopenia and common allergic diseases among children","volume":"77","author":"Chiang","year":"2015","journal-title":"Pediatr Res"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1471-2431-14-199","article-title":"Pediatric complex chronic classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation","volume":"14","author":"Feudtner","year":"2014","journal-title":"BMC Pediatr"},{"key":"R21-20230918","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/adc.71.3.251","article-title":"Intracranial hemorrhage in idiopathic thrombocytopenic purpura","volume":"71","author":"Lilleyman","year":"1994","journal-title":"Arch Dis Child"},{"key":"R22-20230918","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(97)04143-3","article-title":"Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines","volume":"350","author":"Bolton-Maggs","year":"1997","journal-title":"Lancet"},{"key":"R23-20230918","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1055\/s-2001-15255","article-title":"Acute immune thrombocytopenia (ITP) in childhood: Retrospective and prospective survey in Germany","volume":"27","author":"Sutor","year":"2001","journal-title":"Semin Thromb Hemost"},{"key":"R24-20230918","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1177\/000992280404300802","article-title":"Idiopathic thrombocytopenic purpura: a 10-year natural history study at the Children\u2019s Hospital of Alabama","volume":"43","author":"Watts","year":"2004","journal-title":"Clin Pediatrics"},{"key":"R25-20230918","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/MBC.0000000000000646","article-title":"Association between gene polymorphisms and clinical features in idiopathic thrombocytopenic purpura patients","volume":"28","author":"Rezaeeyan","year":"2017","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R26-20230918","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12185-017-2322-1","article-title":"Recent trends in practice patterns and comparisons between immunoglobulin and corticosteroid in pediatric immune thrombocytopenia","volume":"107","author":"Okubo","year":"2018","journal-title":"Int J Hematol"},{"key":"R28-20230918","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1182\/blood-2010-08-302984","article-title":"The Ametican Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia","volume":"117","author":"Neunert","year":"2011","journal-title":"Blood"},{"key":"R29-20230918","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/ajh.21500","article-title":"Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpura","volume":"84","author":"Danese","year":"2009","journal-title":"Am J Hematol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201804000-00024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T13:21:59Z","timestamp":1719753719000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201804000-00024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000001083","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]}}}